SHAREHOLDERS' EQUITY (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||||
|---|---|---|---|---|---|---|---|
Feb. 13, 2025 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
| Options outstanding | 3,705,000 | 4,405,000 | 3,705,000 | 4,405,000 | 4,405,000 | 4,725,000 | |
| Compensation expense for stock option awards | $ 0 | $ 64 | $ (4) | $ 46 | |||
| Exercised | 400,000 | 400,000 | 50,000 | ||||
| Common shares issued on a net settlement basis | 23,155 | ||||||
| Intrinsic value of options exercised | $ 20 | ||||||
| Equity Incentive Plan 2022 | |||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
| Shares issued | 1,020,000 | ||||||
| Maximum share based awards | 17,236,689 | 17,236,689 | |||||
| Term of stock option | 10 years | ||||||
| 10% Rolling Stock Option Plan | |||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
| Options outstanding | 2,685,000 | 2,685,000 | |||||
| Percentage of Vesting On Rolling Stock | 10.00% | ||||||
| Option granted | 0 | ||||||
| Term of stock option | 10 years | ||||||
| X | ||||||||||
- Definition The percentage of vesting provided on rolling stock option plan by the company. No definition available.
|
| X | ||||||||||
- Definition Number of shares issued on a net settlement basis during the current period. No definition available.
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares authorized for issuance under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares issued under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|